Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPICE IV dexmedetomidine trial in older mechanically ventilated critically ill adults
ACTRN12620001088932Phase 4Recruiting
- Sponsor
- Monash University
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 4, randomised, double-blind trial in critical illness comparing Dexmedetomidine with Placebo plus usual care (2 arms). Primary endpoint: All-cause mortality. Started Mar 2022; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
critical illness
Beyond the preview
Go deeper on ACTRN12620001088932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001088932.